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Correlation of the translation with the rotation may be used 
to optimize the targeting accuracy of marker based liver 
SBRT. Possible optimization includes setup with 6D couch 
corrections, treatment margins aligned to the preferred 
directions of motion, and adaptive treatment techniques such 
as MLC tracking that can compensate for both translations 
and rotations during treatment.  
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Purpose/Objective: The aim of this study was the clinical 
validation of a customized eye tracking system (ETS) for non-
invasive tumor localization and automatic motion detection 
in proton therapy of intraocular tumors.  
Materials and Methods: A prototypal ETS was tested in 
clinical proton therapy at Centre Antoine Lacassagne in Nice 
(FR). The device aims at accurate tumor localization by 
applying 3D infrared video-oculography technique. The 
cornea and pupil centers are recognized on the images 
acquired by two calibrated video cameras, exploiting the eye 
reflections produced by two infrared light sources. This 
allows the assessment of the 3D position and orientation of 
the observed eye. A custom-made calibration chessboard 
fitted with radiopaque beads was used to calibrate the ETS 
and the in-room imaging with respect to the treatment room 
isocenter (fig. 1.a). The direct linear transformation (DLT) 
algorithm was applied to perform geometrical calibration of 
the orthogonal X-Ray system using multiple radiographic 
images of the chessboard. Then, the concurrent localization 
of chessboard corners in ETS images and radiopaque beads in 
X-ray projections allows the calibration of the eye tracker 
(fig. 1.b). The ETS reliability in tumor localization was tested 
during the treatment preparation (fig. 1.c-d) of three eye 
cancer patients for proton irradiation. All of them had 
tantalum markers to localize the target volume. Initial 
patient setup error was estimated by acquiring orthogonal X-
ray images. Then, after applying treatment chair corrections, 
a further acquisition was performed for final setup 
verification. The markers position in the X-ray verification 
images were compared with those estimated by the ETS 
according to the detected eye position and orientation. 
Absolute 3D markers localization error for the entire patient 
cohort is shown in table 1. Moreover, when more than two 
markers were clearly distinguishable in X-ray projections, the 
imposed chair transformation is estimated and compared 
with the ETS observed setup correction. 
 
Results: The mean retro-projection error (± standard 
deviation) for the DLT calibration of the X-ray system was 
0.06±0.03 mm. The 3D error on clips position provided by the 
ETS was measured below 0.75 mm, (tab. 1). Moreover, 
rotations and translations of clips between initial and 
verification X-Ray acquisition, as seen by the ETS and the X-
Ray imaging system, are reported. 
 
 
Conclusions: The ETS prototype provides high accuracy in 
target localization and complies with the high standard 
required in proton therapy of intraocular tumors. Future 
activities will be focused on inter-fraction data acquisition to 
test the ETS accuracy and robustness. 
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Purpose/Objective: Intrafraction tumor motion in scanning 
proton therapy may substantially distort the delivered dose 
distribution. These interplay effects are in particular a 
concern for hypofractionated treatments of liver tumors due 
to the large respiratory motion. Most studies of the interplay 
effect have been based on 4D CT scans and do not include 
irregular breathing. In contrast, this study use real 3D organ 
motions recorded during actual treatments. We establish a 
method to calculate the dose delivered to moving targets in 
scanning proton therapy by a commercial treatment planning 
system (TPS), and apply this method to investigate interplay 
effects for a number of liver SBRT patients with known tumor 
motion. 
Materials and Methods: Two three-field scanning proton 
plans (IMPT and single-field-optimization (SFO)) with 4mm 
spot spacing and a mean GTV dose of 18.75Gy per fraction 
were created for sixteen patients who were previously 
treated with three-fraction x-ray SBRT on a linear 
